Low-dose methotrexate administered weekly is an effective corticosteroid-sparing agent for the treatment of the cutaneous manifestations of dermatomyositis
Authors:
- Jeffrey P. CallenJCJeffrey P. Callen
- 1 January 1997
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 36 (1) , 67-71
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Treatment of dermatomyositis with methotrexateJournal of the American Academy of Dermatology, 1995
- Methotrexate Therapy of Psoriasis: Differential Sensitivity of Proliferating Lymphoid and Epithelial Cells to the Cytotoxic and Growth-Inhibitory Effects of MethotrexateJournal of Investigative Dermatology, 1995
- Current treatment of the inflammatory myopathiesCurrent Opinion in Rheumatology, 1994
- Dermatomyositis With Normal Muscle Enzyme ConcentrationsArchives of Dermatology, 1994
- ChlorambucilArthritis & Rheumatism, 1993
- Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: An open study with 20 adult patientsThe American Journal of Medicine, 1991
- Amyopathic dermatomyositis (dermatomyositis siné myositis)Journal of the American Academy of Dermatology, 1991
- Adult-onset polymyositis-dermatomyositis: Description of 25 patients with emphasis on treatmentSeminars in Arthritis and Rheumatism, 1990
- DermatomyositisDisease-a-Month, 1987
- Polymyositis and DermatomyositisNew England Journal of Medicine, 1975